By pointing out clinical trials as part of the fda's approval process for new drugs, the author is attempting to
a.
convince readers that all inds are eventually approved by the fda.
b.
accurately convey the amount of risk involved in taking new drugs.
c.
show readers why access to inds is important to drug development.
d.
persuade the fda to evaluate and approve new drugs more quickly.